An in Vitro Pilot Study of the Role of Factor IX As an Alternative to Bypassing Agents in the Treatment of Breakthrough Bleeds in Patients with Hemophilia a and Inhibitors Treated with Emicizumab

被引:0
作者
Janbain, Maissaa [1 ]
Josset, Laurie [2 ]
Nougier, Christophe [3 ]
Leissinger, Cindy A. [4 ]
Ksayer, Radia [4 ]
Dargaud, Yesim [3 ]
机构
[1] Tulane Univ, Sch Med, Dept Hematol Oncol, New Orleans, LA 70112 USA
[2] Univ Lyon 1, Hemostase & Thrombose UR4609, Lyon, France
[3] Univ Lyon 1, Hemostase & Thrombose UR4609, Bron, France
[4] Tulane Univ, Sch Med, New Orleans, LA 70112 USA
关键词
D O I
10.1182/blood-2023-187217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
empty
未找到相关数据